Advanced Medical Isotope Corporation (OTCMKTS:RDGL) Short Interest Update

Advanced Medical Isotope Corporation (OTCMKTS:RDGL) was the target of a large growth in short interest in April. As of April 30th, there was short interest totaling 70,157 shares, a growth of 160.7% from the April 15th total of 26,910 shares. Based on an average daily trading volume, of 5,024,772 shares, the short-interest ratio is currently 0.0 days. Currently, 0.0% of the shares of the stock are short sold.

Advanced Medical Isotope Stock Performance

Shares of OTCMKTS:RDGL remained flat at $0.07 on Friday. 280,942 shares of the company’s stock were exchanged, compared to its average volume of 2,077,489. Advanced Medical Isotope has a 1-year low of $0.04 and a 1-year high of $0.15. The company has a market cap of $33.47 million, a P/E ratio of -6.78 and a beta of -0.77. The business has a 50-day moving average price of $0.08 and a 200-day moving average price of $0.07.

Advanced Medical Isotope (OTCMKTS:RDGL) last issued its quarterly earnings results on Monday, March 30th. The company reported ($0.01) EPS for the quarter. The company had revenue of $0.02 million for the quarter.

About Advanced Medical Isotope

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc in December 2017. Vivos Inc was incorporated in 1994 and is headquartered in Richland, Washington.